The role of HCV proteins on treatment outcomes
© 2015 Kumthip and Maneekarn. For many years, the standard of treatment for hepatitis C virus (HCV) infection was a combination of pegylated interferon alpha (Peg-IFN-α) and ribavirin for 24-48 weeks. This treatment regimen results in a sustained virologic response (SVR) rate in about 50 % of cases....
Saved in:
Main Authors: | Kattareeya Kumthip, Niwat Maneekarn |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84949942482&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/54556 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
The role of HCV proteins on treatment outcomes
by: Kattareeya Kumthip, et al.
Published: (2018) -
Molecular epidemiology and genotype distributions of noroviruses and sapoviruses in Thailand 2000-2016: A review
by: Kattareeya Kumthip, et al.
Published: (2018) -
Detection of poliovirus infection in children with acute gastroenteritis in Chiang Mai, Thailand
by: Kattareeya Kumthip, et al.
Published: (2018) -
Analysis of mutations in the core and NS5A genes of hepatitis C virus in non-responder and relapser patients after treatment with Peg-IFN-α and ribavirin
by: Kattareeya Kumthip, et al.
Published: (2018) -
Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples
by: Shrikant Dasharath Warkad, et al.
Published: (2019)